| Product NDC: | 62856-602 |
| Proprietary Name: | Targretin |
| Non Proprietary Name: | bexarotene |
| Active Ingredient(s): | 75 mg/1 & nbsp; bexarotene |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE, LIQUID FILLED |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 62856-602 |
| Labeler Name: | Eisai Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021055 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19991229 |
| Package NDC: | 62856-602-10 |
| Package Description: | 1 BOTTLE in 1 CARTON (62856-602-10) > 100 CAPSULE, LIQUID FILLED in 1 BOTTLE |
| NDC Code | 62856-602-10 |
| Proprietary Name | Targretin |
| Package Description | 1 BOTTLE in 1 CARTON (62856-602-10) > 100 CAPSULE, LIQUID FILLED in 1 BOTTLE |
| Product NDC | 62856-602 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | bexarotene |
| Dosage Form Name | CAPSULE, LIQUID FILLED |
| Route Name | ORAL |
| Start Marketing Date | 19991229 |
| Marketing Category Name | NDA |
| Labeler Name | Eisai Inc. |
| Substance Name | BEXAROTENE |
| Strength Number | 75 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Retinoid [EPC],Retinoids [Chemical/Ingredient] |